ArticleInternational journal of radiation oncology, biology, physics2020

Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer.

Jianqing Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.